BMS-275183

Star0

DB12144InvestigationalSmall molecule

BMS-275183 has been used in trials studying the treatment of Tumors and Non-small Cell Lung Cancer.

Formula / weight: C₄₃H₅₉NO₁₆ · 845.936 g/mol (avg)
Code names: BMS-275183

Resolves to

Compound

UNIIUQC681JJIVCAS355113-98-3PubChem6918594

Structure

InChIKeyAHXICHPPXIGCBN-GPWPDEGDSA-NSMILES

COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2=CC=CC=C2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(C)=C([C@@H](OC(C)=O)C1=O)C2(C)C

What you can answer from here — as of July 07, 2026

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of BMS-275183, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account